Co-founded a biotech company developing a strain-engineering platform to improve microbial production performance and reduce manufacturing costs
Co-founded a biotech company developing a strain-engineering platform to improve microbial production performance and reduce manufacturing costs. * Built the commercial strategy, positioning, pricing model, and customer acquisition process * Engaged 9 of 12 priority companies, advancing five into commercial discussions and three to term sheet or LOI stage * Negotiated an LOI representing up to $1.7M in potential milestone payments and reached commercial alignment on three additional opportunities representing more than $2M in potential value * Led customer development, partnership negotiations, and commercial agreement structuring